Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.

Abstract

Fifty patients with intermediate- or high-grade non-Hodgkin's lymphoma (NHL) who had relapsed after a complete remission induced by an Adriamycin-containing chemotherapy regimen participated in this prospective pilot study. The patients ranged in age from 16 to 60 years (median 42 years). All patients received dexamethasone, high-dose cytarabine, and… (More)

3 Figures and Tables

Cited By

Sort by:

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

B. Tessoulin, P. Thomare, +18 authors Steven Le Gouill
Annals of Hematology
2017

Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.

Paul C Kruger, Julian P Cooney, J Harvey Turner
Cancer biotherapy & radiopharmaceuticals
2012

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

2017

References

Sort by:

Showing 1-10 of 28 references

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

B Coiffier, C Gisselbrecht, R Herbrecht, H Tilly, A Bosly, N Brousse
Journal of clinical oncology : official journal…
1989

F Cabanillas, S Jagannath, T Philip
National Cancer Institute,
1989

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

W S Velasquez, F Cabanillas, +7 authors F Swan
Blood
1988

T Philip, J Armitage, +9 authors F Chauvin
Proceedings of the Third International Symposium,
1987

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

T Philip, J O Armitage, +7 authors M Flesh
The New England journal of medicine
1987

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

F R Appelbaum, K M Sullivan, +7 authors J E Sanders
Journal of clinical oncology : official journal…
1987

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

T Philip, P Biron, +7 authors J P Laporte
European journal of cancer & clinical oncology
1986

The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma.

T Philip, R Pinkerton, +4 authors M Favrot
Clinics in haematology
1986

Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation.

B Mascret, D Maraninchi, +7 authors G Novakovitch
European journal of cancer & clinical oncology
1986

S Gulati, B Shank, +9 authors B Clarkson
1985

Slides referencing similar topics

Allogeneic Bone Marrow Transplant
Oct 16, 2017
Provide an overview of Bone Marrow Transplantation
Aug 27, 2017
Blood Transfusion Bone Marrow Transplant Organ Transplants
Gregory Underhill + 1 • Oct 18, 2017
Show More

Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.

Abstract

Topics

3 Figures and Tables

Cited By

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

References

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

Management of recurrent or refractory disease, in Magrath I (ed): Advances in Lymphoma

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

An international randomized study of relapsed diffuse intermediate and high grade lymphoma in adults, in Dicke KA, Spitzer G, Zander AR (eds): Autologous Bone Marrow Transplantation

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma.

Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation.

Autologous stem cell transplant for poor prognosis lymphoma, in Cavalli F (ed), Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances

Slides referencing similar topics

Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.

Abstract

Topics

3 Figures and Tables

Cited By

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.

Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

Comparison of Chop Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-hodgkin’s Lymphoma

References

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

Management of recurrent or refractory disease, in Magrath I (ed): Advances in Lymphoma

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

An international randomized study of relapsed diffuse intermediate and high grade lymphoma in adults, in Dicke KA, Spitzer G, Zander AR (eds): Autologous Bone Marrow Transplantation

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma.

Treatment of malignant lymphoma with high dose of chemo or chemoradiotherapy and bone marrow transplantation.

Autologous stem cell transplant for poor prognosis lymphoma, in Cavalli F (ed), Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances

Similar Papers

Slides referencing similar topics